Loading…
Central Iowa Electronic Cigarettes Inc manufactured and sold e-liquid tobacco products through their website without obtaining required premarket authorization orders, violating the Family Smoking Prevention and Tobacco Control Act. The company failed to comply with FDA regulations governing newly deemed tobacco products (ENDS), which have been subject to FDA jurisdiction since August 8, 2016, and require marketing authorization before legal sale in the United States. The FDA determined that the e-liquids listed on the company's website met the definition of tobacco products under the Federal Food, Drug, and Cosmetic Act but lacked the necessary premarket approval for legal distribution.